review Open AccessTop 1% cited
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
American Journal Of Pathology · 1999 · Vol. 154(2) · pp. 313–323
Ricardo V. Lloyd✉(Mayo Clinic)Lori A. Erickson(Mayo Clinic)Long Jin(Mayo Clinic)Elzbieta Kulig(Mayo Clinic)Xiang Qian(Mayo Clinic)John C. Cheville(Mayo Clinic)Bernd W. Scheithauer(Mayo Clinic)
Cancer-related Molecular PathwaysEpigenetics and DNA MethylationHedgehog Signaling Pathway StudiesCancer researchBiologyCell cycleCyclin-dependent kinaseCyclinTransforming growth factorCell growthCyclin-dependent kinase 4KinaseCell biology
MeSH terms
Cell CycleEnzyme InhibitorsFemaleHumansMaleMicrotubule-Associated ProteinsNeoplasmsPrognosisGene ExpressionCell Cycle ProteinsCyclin-Dependent KinasesTumor Suppressor ProteinsCyclin-Dependent Kinase Inhibitor p27
Citations
590
FWCI
18.75
field-weighted impact
References
144
Percentile
100%
vs. same field & year
Citations per year
Cited by
The proteasome: a novel target for cancer chemotherapy
Leukemia · 2002 · 540 citations
References
Cancer: Principles and Practice of Oncology.
Annals of Internal Medicine · 1991 · 8,541 citations
Hormone-Induced Proliferation and Differentiation of Granulosa Cells: A Coordinated Balance of the Cell Cycle Regulators Cyclin D2 and p27<sup>Kip1</sup>
Molecular Endocrinology · 1998 · 431 citations
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
Genes & Development · 1994 · 1,972 citations
Inhibitors of mammalian G1 cyclin-dependent kinases.
Genes & Development · 1995 · 3,256 citations
WAF1, a potential mediator of p53 tumor suppression
Cell · 1993 · 8,369 citations
Ubiquitin, proteasomes, and the regulation of intracellular protein degradation
Current Opinion in Cell Biology · 1995 · 893 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.